I have expertise in diabetes and wound healing. My studies began with the characterization of proteins belonging to the insulin signaling pathway in skin of rodents. We had studied products that could improve the healing process by activating this pathway. We studied the role of insulin itself in healing, as well as atorvastatin and topiramate. In addition, we explored the effect of fatty acids on skin lesions. Our studies showed that topical treatment with docosahexaenoic fatty acid improved the healing of skin wounds, through the activation of the G 120 protein-coupled receptor and its association with β-arrestin 2. We also decided to explore new bioactive materials for improving wound healing. We developed hydrogels embedded in a poly (acrylic acid) matrix (PAA), with Snitrosoglutathione (GSNO). This hydrogel was able to improve wound healing by increasing angiogenesis and organization of collagen fibers. Likewise, we demonstrated that a self-expanding collagen sponge with release of nitric oxide increases the migration and infiltration of leukocytes, macrophages, and keratinocytes into the injured tissue, as well as neovascularization and collagen deposition, which are correlated with wound closure. We studied a new fibrin matrix complex of γγ′F1 (γγ′Fibrinogen) and pFN (plasma fibronectin) in the presence of highly active thrombin and recombinant Factor XIII (rFXIIIa). Dermal wounds of mice that were sealed by γγ′F1: pFN fibrin exhibited accelerated and improved healing.